Related Experiment Video
Updated: Aug 15, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Bone marrow failure in children
1Jack and Lucy Clark Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.
Insights
Pediatric bone marrow failure is increasingly understood through cellular biology and molecular genetics. Advances in diagnosis and treatments like bone marrow transplantation and gene therapy bridge laboratory research and patient care.
Area of Science:
- Hematology
- Pediatric Medicine
- Molecular Genetics
- Cellular Biology
Background:
- Bone marrow failure (BMF) in children presents complex challenges at the intersection of clinical medicine and basic science.
- Understanding the pathophysiology of BMF is crucial for developing effective treatments.
- Modern scientific advancements are key to improving outcomes for pediatric BMF patients.
Purpose of the Study:
- To summarize recent progress in the understanding, diagnosis, and treatment of pediatric bone marrow failure states.
- To highlight the integration of laboratory research and clinical practice in advancing BMF care.
- To emphasize the role of cellular biology and molecular genetics in pediatric hematology.
Main Methods:
- Review of current research and clinical findings in pediatric bone marrow failure.
- Integration of data from laboratory bench research and patient bedside observations.
- Synthesis of advancements in diagnostic techniques and therapeutic modalities.
Main Results:
- Significant progress has been made in elucidating the pathophysiology of various pediatric bone marrow failure disorders.
- Novel diagnostic tools have improved the identification of specific BMF conditions.
- Effective treatments, including bone marrow transplantation and gene therapy, are increasingly informed by scientific understanding.
Conclusions:
- The union of laboratory research and clinical practice is driving significant advancements in pediatric bone marrow failure.
- Continued integration of molecular genetics and cellular biology is essential for future progress in BMF diagnosis and treatment.
- Improved understanding and treatment strategies offer better outcomes for children with bone marrow failure.
Abstract:
Bone marrow failure in the pediatric patient places the hematologist at the junction of clinical medicine, cellular biology, and molecular genetics. The pathophysiology of these disorders is rapidly being elucidated in many laboratories. Treatments such as bone marrow transplantation and the nascent modality of gene therapy are firmly grounded in these modern sciences. This year's progress in the understanding, diagnosis, and treatment of a wide variety of predominantly pediatric bone marrow failure states is a direct result of the union between the "laboratory bench and the patient bedside."
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

